Test ID SSB SS-B/La Antibodies, IgG, Serum
Useful For
Evaluating patients with signs and symptoms of a connective tissue disease in whom the test for antinuclear antibodies is positive
Testing Algorithm
See Connective Tissue Disease Cascade (CTDC) in Special Instructions.
Special Instructions
Method Name
Multiplex Flow Immunoassay
Reporting Name
SS-B/La Ab, IgG, SSpecimen Type
SerumContainer/Tube:
Preferred: Serum gel
Acceptable: Red top
Specimen Volume: 0.5 mL
Specimen Minimum Volume
0.35 mL
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
Serum | Refrigerated (preferred) | 21 days |
Frozen | 21 days |
Clinical Information
SS-B/La is an extractable nuclear antigen (ENA) composed of a 48-kD protein combined with RNA species. SS-B/La antibodies are found primarily in patients with Sjogren’s syndrome or lupus erythematosus (LE), where they occur with frequencies of approximately 60% and 15%, respectively.(1,2) SS-B/La antibodies occur only infrequently in the absence of SS-A/Ro antibodies.
SS-B/La is 1 of 4 autoantigens commonly referred to as extractable nuclear antigens (ENAs). The other ENAs are SS-A/Ro, RNP, and Sm. Each ENA is composed of 1 or more proteins associated with cytoplasmic or small nuclear RNA species (snRNP) ranging in size from 80 to 350 nucleotides. Antibodies to ENAs are common in patients with connective tissue diseases (systemic rheumatic diseases) including LE, mixed connective tissue disease, Sjogren's syndrome, scleroderma (systemic sclerosis), and polymyositis/dermatomyositis.
See Connective Tissue Disease Cascade (CTDC) in Special Instructions and Optimized Laboratory Testing for Connective Tissue Diseases in Primary Care: The Mayo Connective Tissue Diseases Cascade in Publications.
Reference Values
<1.0 U (negative)
≥1.0 U (positive)
Reference values apply to all ages.
Cautions
Testing for SS-B/La antibodies is not useful in patients without demonstrable antinuclear antibodies.
Day(s) Performed
Monday through Saturday; 4 p.m.
Report Available
1 dayPerforming Laboratory

Test Classification
This test has been cleared or approved by the U.S. Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
86235